Literature DB >> 22312614

PURLs: would this long-acting bronchodilator be better for your patient?

Mark Gwynne1, Anne Mounsey.   

Abstract

Tiotropium outperformed salmeterol in reducing the frequency of exacerbations in patients with moderate-to-severe COPD.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22312614      PMCID： PMC3273926     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  9 in total

1.  Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD.

Authors:  Marc Miravitlles; Cristina Murio; Tina Guerrero; Ramon Gisbert
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

2.  Tiotropium versus salmeterol for the prevention of exacerbations of COPD.

Authors:  Claus Vogelmeier; Bettina Hederer; Thomas Glaab; Hendrik Schmidt; Maureen P M H Rutten-van Mölken; Kai M Beeh; Klaus F Rabe; Leonardo M Fabbri
Journal:  N Engl J Med       Date:  2011-03-24       Impact factor: 91.245

3.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.

Authors:  R Casaburi; D A Mahler; P W Jones; A Wanner; Pedro G San; R L ZuWallack; S S Menjoge; C W Serby; T Witek
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

4.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

5.  Knowledge and attitudes of family physicians coming to COPD continuing medical education.

Authors:  Barbara P Yawn; Peter C Wollan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

6.  A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.

Authors:  James F Donohue; Jan A van Noord; Eric D Bateman; Stephen J Langley; Angela Lee; Theodore J Witek; Steven Kesten; Lesley Towse
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

7.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Bartolome Celli; Stephen Senn; Deborah Burkhart; Steven Kesten; Shailendra Menjoge; Marc Decramer
Journal:  N Engl J Med       Date:  2008-10-05       Impact factor: 91.245

Review 8.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Authors:  Klaus F Rabe; Suzanne Hurd; Antonio Anzueto; Peter J Barnes; Sonia A Buist; Peter Calverley; Yoshinosuke Fukuchi; Christine Jenkins; Roberto Rodriguez-Roisin; Chris van Weel; Jan Zielinski
Journal:  Am J Respir Crit Care Med       Date:  2007-05-16       Impact factor: 21.405

9.  Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians.

Authors:  Gregory D Salinas; James C Williamson; Ravi Kalhan; Byron Thomashow; Jodi L Scheckermann; John Walsh; Maziar Abdolrasulnia; Jill A Foster
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.